Enalapril (CED0002046)

Record Information
Version1.0
Creation Date2016-05-22 03:40:27 UTC
Update Date2026-08-20 06:30:26 UTC
Accession NumberCHEM016685
Identification
Common NameEnalapril
ClassSmall Molecule
Description
Enalapril is an organic compound with the formula C20H28N2O5 and an average molecular weight of 376.45 g/mol. Enalapril belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. It acts as an inhibitor of the protein target Angiotensin-converting enzyme (ACE). The compound is found in or released from three recorded sources: antennas in electrical and electronic equipment, drinking water in drinking water and water supply, and ACE inhibitors in healthcare, pharmaceuticals, and veterinary products. The recorded exposure route for this substance is oral.
Contaminant Type
  • Human Neurotoxin
Chemical Structure
Synonyms
ValueSource
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-prolineChEBI
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acidChEBI
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl esterChEBI
AnalaprilChEBI
EnalaprilaChEBI
EnalaprilumChEBI
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylateGenerator
Enalapril maleateHMDB
EnalaprilatHMDB
RenitekHMDB
Maleate, enalaprilHMDB
RenitecHMDB
Chemical FormulaC20H28N2O5
Average Molecular Mass376.447 g/mol
Monoisotopic Mass376.200 g/mol
CAS Registry Number75847-73-3
IUPAC Name(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid
Traditional Nameenalapril
SMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O
InChI IdentifierInChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1
InChI KeyGBXSMTUPTTWBMN-XIRDDKMYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-l-alpha-amino acid
  • Proline or derivatives
  • Alpha-amino acid ester
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • Pyrrolidine carboxylic acid or derivatives
  • Pyrrolidine carboxylic acid
  • N-acylpyrrolidine
  • Fatty acid ester
  • Aralkylamine
  • Dicarboxylic acid or derivatives
  • Fatty acyl
  • Benzenoid
  • Monocyclic benzene moiety
  • Pyrrolidine
  • Tertiary carboxylic acid amide
  • Amino acid or derivatives
  • Carboxamide group
  • Carboxylic acid ester
  • Amino acid
  • Azacycle
  • Secondary aliphatic amine
  • Carboxylic acid
  • Organoheterocyclic compound
  • Secondary amine
  • Hydrocarbon derivative
  • Amine
  • Organopnictogen compound
  • Organic oxygen compound
  • Carbonyl group
  • Organic oxide
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.21 g/LALOGPS
logP0.19ALOGPS
logP0.59ChemAxon
logS-3.2ALOGPS
pKa (Strongest Acidic)3.67ChemAxon
pKa (Strongest Basic)5.2ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area95.94 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity99.57 m³·mol⁻¹ChemAxon
Polarizability40.41 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0udi-4329000000-0ccc991d6f82c8023381Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-004i-4139100000-e739549506767919633fNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0809000000-0e192d1573028e60641cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-003r-1859000000-8b202071e8860792a59fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-02ai-0920000000-a43751d817c0f98bc5b6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0591000000-1e07b9fe2aaace58211eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-e737fba7359f446dfefaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0096000000-f899a068af97bea539acNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-003r-1859000000-a8e3ac5e4d170e35772cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-02t9-0900000000-0f67eb2d8b2e7821015cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0591000000-9695db764f080d9ae857Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0809000000-0e192d1573028e60641cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0095000000-f899a068af97bea539acNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0059-0239000000-feb01e2c02b331eea247Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-5893000000-141cda4f7233f214c8dcNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0296-6910000000-189f3dddcaf5004e885fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-1019000000-ae65ecb00dc3ab6e3701Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03gs-5559000000-d8643ca2f50322b85449Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ot-8921000000-5383f963d934648ca615Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-0129000000-f7705eec0d29efd988c2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01sl-3944000000-04f3a7836b5b57821688Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0903-3900000000-cb0bc55987e5b9460684Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-0109000000-ec7a71512e90259b372cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-3913000000-89b99fdc1118ca034b01Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-3900000000-294402e5b0098d7dc45eNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
5710.0Log mg/kg[3200:10000]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
115Drinking waterDrinking water & water supplyNot Available
295ACE inhibitorsHealthcare, pharmaceuticals & veterinary productsNot Available
506AntennasElectrical & Electronic EquipmentNot Available
Pathways
4 pathways
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureAngiotensin-converting enzymeP12822Oryctolagus cuniculusPredicted (SEA)0.0778492
Angiotensin-converting enzyme structureClick to view 3D structureAngiotensin-converting enzymeP12821HumansPredicted (SEA)0.0778492
Click to view 3D structureAngiotensin-converting enzymeP47820Rattus norvegicusPredicted (SEA)0.0778492
Click to view 3D structureAngiotensin-converting enzyme 2Q5EGZ1Rattus norvegicusPredicted (SEA)0.0778492
Click to view 3D structureNeprilysinP08049Oryctolagus cuniculusPredicted (SEA)6.77288
Renin structureClick to view 3D structureReninP00797HumansPredicted (SEA)15.1027
Click to view 3D structureNeprilysinP07861Rattus norvegicusPredicted (SEA)5.60514
Click to view 3D structureAngiotensin-converting enzymeP09470Mus musculusPredicted (SEA)0.311397
Click to view 3D structureProlyl endopeptidaseP23687Sus scrofaPredicted (SEA)2.33548
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)176.173
Xaa-Pro aminopeptidase 1 structureClick to view 3D structureXaa-Pro aminopeptidase 1Q9NQW7HumansPredicted (SEA)6.07224
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)201.007
Click to view 3D structureDelta-type opioid receptorP32300Mus musculusPredicted (SEA)163.406
Click to view 3D structureProlyl endopeptidaseQ9XTA2Bos taurusPredicted (SEA)2.02408
Click to view 3D structureDelta-type opioid receptorP33533Rattus norvegicusPredicted (SEA)146.746
Prothrombin structureClick to view 3D structureProthrombinP00734HumansPredicted (SEA)92.407
Click to view 3D structureFK506 binding protein 12Q8QGU2Gallus gallusPredicted (SEA)1.55698
Click to view 3D structureXaa-Pro aminopeptidase 2Q99MA2Rattus norvegicusPredicted (SEA)4.12601
Click to view 3D structureProlyl endopeptidaseQ9QUR6Mus musculusPredicted (SEA)1.24559
Click to view 3D structureMu-type opioid receptorP97266Cavia porcellusPredicted (SEA)178.742
Breast cancer type 1 susceptibility protein structureClick to view 3D structureBreast cancer type 1 susceptibility proteinP38398HumansPredicted (SEA)15.1806
Click to view 3D structureProlyl endopeptidaseP27028Elizabethkingia meningosepticaPredicted (SEA)2.33548
Click to view 3D structureXaa-Pro aminopeptidase 2O43895HumansPredicted (SEA)3.50322
Xaa-Pro dipeptidase structureClick to view 3D structureXaa-Pro dipeptidaseP12955HumansPredicted (SEA)7.62922
Click to view 3D structureSubstance-P receptorP14600Rattus norvegicusPredicted (SEA)88.7481
Concentrations
Not Available
External Links
DrugBank IDDB00584
HMDB IDHMDB0014722
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDCPD0-2065
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkEnalapril
Chemspider ID4534998
ChEBI ID4784
PubChem Compound ID40466924
Kegg Compound IDC06977
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. D.P. Ip and G.S. Brenner, in K. Florey (Editor), Analytical Profiles of Drug Substances, Vol. 16, Aca- demic Press, London, 1987, pp. 207-243.
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=10669559
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=23030053
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=23413003